A special communication in JAMA says medicines alone cannot solve the global obesity crisis. While GLP-1 drugs are a major advance, WHO urges countries to adopt integrated, equitable obesity care combining long-term medication, behavioral therapy, prevention policies and health promotion. Obesity must be managed as a chronic disease through system-wide reforms beyond drugs.